In this conversation, Sara Robinson, senior associate healthcare architect at McMillan Pazdan Smith Architecture, and Jamie Feinour, vice president of operations at Novant Health Presbyterian Medical ...

If a person carries a mutation(s) in the DPYD gene, certain chemotherapies (fluorouracil (5-FU) or capecitabine (Xeloda or ...

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...

Most cells in the body send out little messengers called extracellular vesicles that carry proteins, lipids, and other ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...

Josh Carpenter, who filled prominent positions with Southern Research and the city of Birmingham, has joined a Florida cancer ...

A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have ...

Josh Carpenter, who will serve as the president of Speros and Moffitt's chief integration officer, will lead the 775-acre ...